Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual-Dosing of Aspirin and Clopidogrel in CAD and Healthy Subjects
NCT01011257Phase 4Withdrawn
- Start
- Sep 2009
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, clopidogrel in coronary artery disease (CAD). Planned start Sep 2009; status: withdrawn.
02
Drugs
aspirinclopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01011257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011257.